Department of Ultrasound, Guangdong Province Traditional Chinese Medical Hospital, 111, Dade Road, Yuexiu District, Guangzhou, Guangdong, China.
Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, 107, Yanjiangxi Road, Yuexiu District, Guangzhou, Guangdong, PR China.
BMC Endocr Disord. 2022 Apr 2;22(1):87. doi: 10.1186/s12902-022-01007-5.
Patients with type 2 diabetes mellitus (T2DM) are susceptible to developing symptomatic peripheral arterial disease (PAD). As a proven vasodilator and antiplatelet agent, the efficiency of Beraprost sodium (BPS) on the prevention of arteries occlusion and stiffness in T2DM patients with PAD has not yet been fully investigated.
From July 2010 to April 2012, 64 Patients enrolled were randomly assigned to the combined therapy group (n=32), which received combination therapy with BPS (60 μg/day) and aspirin (100 mg/day), or to the control group (n=32), which only received aspirin (100 mg/day). After randomization, the patients were followed up at years 0, 1, 2, 3, 4, and 5 with the evaluation of carotid intima-media thickness (CIMT), pulse wave velocity (PWV), inner artery diameter, stenosis rate, and medial arterial calcification (MAC) of lower limb arteries via high-resolution ultrasound measurement. Adverse events were also recorded in each visit.
There was no significant change of the CIMT during the follow-up in both groups when compared to the baseline. Similar results were also observed in the PWV measurement. Significantly increases in the inner artery diameter of the dorsal pedal artery and posterior tibial artery were observed in patients with BPS and aspirin administration during the follow-up. Patients in the combined therapy group experienced marked improvement of MAC in the dorsal pedal artery and posterior tibial artery at the end of the follow-up. No significant difference in the adverse events was found between the combined therapy group and the aspirin group.
The combined therapy of BPS and aspirin showed a protective effect on arteries occlusion and stiffness in T2DM patients with PAD, along with a significant improvement of inner artery diameter and MAC in lower limbs.
http://www.chictr.org.cn , ChiCTR-TRC-10000919. Prospectively registered on 2010/06/29.
2 型糖尿病(T2DM)患者易发生有症状的外周动脉疾病(PAD)。贝前列素钠(BPS)作为一种已被证实的血管扩张剂和抗血小板药物,其在预防 T2DM 合并 PAD 患者动脉闭塞和僵硬方面的疗效尚未得到充分研究。
2010 年 7 月至 2012 年 4 月,纳入 64 例患者,随机分为联合治疗组(n=32),给予 BPS(60μg/天)和阿司匹林(100mg/天)联合治疗;或对照组(n=32),仅给予阿司匹林(100mg/天)。随机分组后,通过高分辨率超声测量,对颈动脉内膜中层厚度(CIMT)、脉搏波速度(PWV)、内动脉直径、狭窄率和下肢动脉中层动脉钙化(MAC)进行随访评估,随访时间分别为 0 年、1 年、2 年、3 年、4 年和 5 年。在每次就诊时还记录不良事件。
与基线相比,两组患者在随访期间 CIMT 均无明显变化,PWV 测量也得到了类似的结果。在接受 BPS 和阿司匹林治疗的患者中,随访期间背侧足动脉和后胫动脉的内动脉直径明显增加。联合治疗组患者在随访结束时,背侧足动脉和后胫动脉的 MAC 显著改善。联合治疗组和阿司匹林组的不良事件发生率无显著差异。
BPS 和阿司匹林联合治疗对 T2DM 合并 PAD 患者的动脉闭塞和僵硬有保护作用,同时显著改善下肢内动脉直径和 MAC。
http://www.chictr.org.cn ,ChiCTR-TRC-10000919。于 2010 年 6 月 29 日前瞻性注册。